Results 371 to 380 of about 266,614 (380)

Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy

Nature Neuroscience, 2017
D. Corey
semanticscholar   +1 more source

Safety of antisense oligonucleotide and siRNA-based therapeutics.

Drug Discovery Today, 2017
X. Chi, Philip Gatti, T. Papoian
semanticscholar   +1 more source

Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer

Pharmaceutical Research, 2017
Xinwei Cheng, Qibing Liu, Hong Li, Chen Kang, Yang Liu, Tianqi Guo, Ke Shang, Chengyun Yan, Guang Cheng, Robert J. Lee   +9 more
semanticscholar   +1 more source

Antisense Oligonucleotides

1997
openaire   +1 more source

Analytics of Antisense Oligonucleotides

2022
Sylwia Studzińska, Anna Kilanowska, Łukasz Nuckowski, Bogusław Buszewski   +3 more
openaire   +1 more source

Antisense oligonucleotide strategies in neuropharmacology

Trends in Pharmacological Sciences, 1994
openaire   +3 more sources

Antisense Oligonucleotide Therapies

Toxicologic pathology (Print), 2015
Kendall S. Frazier
semanticscholar   +1 more source

On the Quality Control of Antisense Oligonucleotides

Antisense and Nucleic Acid Drug Development, 1996
F, Eckstein, A M, Krieg, C A, Stein, S, Agrawal, S, Beaucage, P D, Cook, S, Crooke, M J, Gait, A, Gewirtz, C, Hélène, P, Miller, R, Narayanan, A, Nicolin, P, Nielsen, E, Ohtsuka, H, Seliger, W, Stec, D, Tidd, R, Wagner, J, Zon   +19 more
openaire   +3 more sources

Antisense oligonucleotide development for the treatment of muscular dystrophies

, 2016
Tri Le Bao, R. Veedu, S. Fletcher, S. Wilton   +3 more
semanticscholar   +1 more source

Antisense oligonucleotides in cancerology

European Journal of Cancer, 1997
C. Malvy, Patrick Couvreur, Valerie Helin, E. Fattal, Jean-Remy Bertrand   +4 more
openaire   +2 more sources